Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.

Whittam DH, Cobo-Calvo A, Lopez-Chiriboga AS, Pardo S, Gornall M, Cicconi S, Brandt A, Berek K, Berger T, Jelcic I, Gombolay G, Oliveira LM, Callegaro D, Kaneko K, Misu T, Capobianco M, Gibbons E, Karthikeayan V, Brochet B, Audoin B, Mathey G, Laplaud D, Thouvenot E, Cohen M, Tourbah A, Maillart E, Ciron J, Deschamps R, Biotti D, Rostasy K, Neuteboom R, Hemingway C, Forsyth R, Matiello M, Webb S, Hunt D, Murray K, Hacohen Y, Lim M, Leite MI, Palace J, Solomon T, Lutterotti A, Fujihara K, Nakashima I, Bennett JL, Pandit L, Chitnis T, Weinshenker BG, Wildemann B, Sato DK, Kim SH, Huda S, Kim HJ, Reindl M, Levy M, Jarius S, Tenembaum S, Paul F, Pittock S, Marignier R, Jacob A

Open source

DOI: 10.1016/j.msard.2020.102251
Published: 2020 Sep
Container: Multiple sclerosis and related disorders
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.msard.2020.102251,
  title = {Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.},
  author = {Whittam DH and Cobo-Calvo A and Lopez-Chiriboga AS and Pardo S and Gornall M and Cicconi S and Brandt A and Berek K and Berger T and Jelcic I and Gombolay G and Oliveira LM and Callegaro D and Kaneko K and Misu T and Capobianco M and Gibbons E and Karthikeayan V and Brochet B and Audoin B and Mathey G and Laplaud D and Thouvenot E and Cohen M and Tourbah A and Maillart E and Ciron J and Deschamps R and Biotti D and Rostasy K and Neuteboom R and Hemingway C and Forsyth R and Matiello M and Webb S and Hunt D and Murray K and Hacohen Y and Lim M and Leite MI and Palace J and Solomon T and Lutterotti A and Fujihara K and Nakashima I and Bennett JL and Pandit L and Chitnis T and Weinshenker BG and Wildemann B and Sato DK and Kim SH and Huda S and Kim HJ and Reindl M and Levy M and Jarius S and Tenembaum S and Paul F and Pittock S and Marignier R and Jacob A},
  year = {2020},
  journal = {Multiple sclerosis and related disorders},
  doi = {10.1016/j.msard.2020.102251},
  url = {https://doi.org/10.1016/j.msard.2020.102251}
}

RIS

TY  - JOUR
TI  - Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
AU  - Whittam DH
AU  - Cobo-Calvo A
AU  - Lopez-Chiriboga AS
AU  - Pardo S
AU  - Gornall M
AU  - Cicconi S
AU  - Brandt A
AU  - Berek K
AU  - Berger T
AU  - Jelcic I
AU  - Gombolay G
AU  - Oliveira LM
AU  - Callegaro D
AU  - Kaneko K
AU  - Misu T
AU  - Capobianco M
AU  - Gibbons E
AU  - Karthikeayan V
AU  - Brochet B
AU  - Audoin B
AU  - Mathey G
AU  - Laplaud D
AU  - Thouvenot E
AU  - Cohen M
AU  - Tourbah A
AU  - Maillart E
AU  - Ciron J
AU  - Deschamps R
AU  - Biotti D
AU  - Rostasy K
AU  - Neuteboom R
AU  - Hemingway C
AU  - Forsyth R
AU  - Matiello M
AU  - Webb S
AU  - Hunt D
AU  - Murray K
AU  - Hacohen Y
AU  - Lim M
AU  - Leite MI
AU  - Palace J
AU  - Solomon T
AU  - Lutterotti A
AU  - Fujihara K
AU  - Nakashima I
AU  - Bennett JL
AU  - Pandit L
AU  - Chitnis T
AU  - Weinshenker BG
AU  - Wildemann B
AU  - Sato DK
AU  - Kim SH
AU  - Huda S
AU  - Kim HJ
AU  - Reindl M
AU  - Levy M
AU  - Jarius S
AU  - Tenembaum S
AU  - Paul F
AU  - Pittock S
AU  - Marignier R
AU  - Jacob A
PY  - 2020
JO  - Multiple sclerosis and related disorders
DO  - 10.1016/j.msard.2020.102251
UR  - https://doi.org/10.1016/j.msard.2020.102251
ER  -

APA

DH, W., A, C., AS, L., S, P., M, G., S, C., A, B., K, B., T, B., I, J., G, G., LM, O., D, C., K, K., T, M., M, C., E, G., V, K., B, B., B, A., G, M., D, L., E, T., M, C., A, T., E, M., J, C., R, D., D, B., K, R., R, N., C, H., R, F., M, M., S, W., D, H., K, M., Y, H., M, L., MI, L., J, P., T, S., A, L., K, F., I, N., JL, B., L, P., T, C., BG, W., B, W., DK, S., SH, K., S, H., HJ, K., M, R., M, L., S, J., S, T., F, P., S, P., R, M., & A, J. (2020). Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.. Multiple sclerosis and related disorders. https://doi.org/10.1016/j.msard.2020.102251

Source records

pubmed · retrieved 2026-09-25T22:15:51.661Z